Patient P-02517

Synthetic patientMETA-24 · Day 173 · 55–64 · M · baseline S12Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

21%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S12
Day 113 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 113.

Primary contributors, last 14 days

Toxicity-19
GI instability+4
Inflammatory activity-3
Nutritional resilience-2
Treatment adherence-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

55 min

stable · +1.2 vs previous 14 d

Sleep duration

Wearable

6.4 h

stable · -0.1 vs previous 14 d

Energy level

Daily log

5.3/10

improving · +0.7 vs previous 14 d

Steps

Wearable

5,735

stable · +122 vs previous 14 d

GI burden

Companion

22.5/100

improving · -5.0 vs previous 14 d

Adherence

Companion

81.3 %

stable · +2.0 vs previous 14 d

Sleep quality

Wearable

47.4/100

improving · +2.8 vs previous 14 d

Glucose, CGM daily mean

CGM

125 mg/dL

stable · -2.1 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 70 from the failing basin, 30 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +6.6
Protein
supporter · GI -3.7 next day

Main detractors to watch

Antibiotic course
perturbation · steering -4.7
Dietary drift
perturbation · steering -2.6

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.7supporter · 95%
Insoluble fibre
-1.1no signal · 29%
Ultra-processed food
+1.1no signal · 31%
Histamine load
+0.9no signal · 30%
Caffeine
+0.7no signal · 20%
Alcohol
+0.7no signal · 19%
Dietary fat load
-0.2no signal · 15%
Simple carbohydrates
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Autonomic recovery ↓20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.9 · butyrate capacity 58/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 61 ms
Sleep: 6.2 h
Steps: 6,564
Resting HR: 70 bpm

Daily log: GI score 23, nutritional resilience 66, adherence 81.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02031	45%	S12	AD-05	improved	47
P-02479	41%	S13	DT-01	improved	48
P-02484	39%	S15	GI-04	improved	49
P-02494	38%	S09	GI-04	improved	47
P-02033	37%	S06	GI-04	improved	51
P-02218	37%	S01	DT-01	improved	61
P-02223	37%	S20	HY-01	improved	49
P-02303	37%	S15	GI-04	improved	48
P-02339	37%	S03	DT-01	improved	50
P-02455	37%	S09	DT-01	improved	50
P-02586	37%	S18	DT-01	improved	56
P-02645	37%	S02	HY-01	improved	56